Report Type : Therapy Reports
Report Category : Genito Urinary and Sexual Diseases
Report Subcategory : Chronic Kidney Disease or Chronic Renal Failure
Price : 2999.00
Date : December 2023
Chronic Kidney Disease or Chronic Renal Failure : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing
Chronic kidney disease (CKD):
Chronic kidney disease (CKD) is a common, progressive condition that affects more than 10% of the world's population:
Prevalence
CKD is more prevalent in older people, women, racial minorities, and people with diabetes or hypertension. It's a major cause of mortality worldwide, especially in low- and middle-income countries.
Causes
CKD can be caused by many factors, including diabetic nephropathy, hypertensive nephrosclerosis, and primary and secondary glomerulopathies.
Symptoms
Many people with CKD don't have symptoms until the disease is advanced, but symptoms can include foamy urine, frequent or infrequent urination, itchy or dry skin, fatigue, nausea, loss of appetite, and weight loss.
Complications
CKD can lead to end-stage kidney disease (ESKD), cardiovascular disease, acute kidney injury (AKI), and increased hospital admissions.
Management
Treatment for CKD includes adjusting drug doses based on estimated glomerular filtration rate (GFR) and renal replacement therapy.
CKD is diagnosed when there's evidence of kidney damage for more than three months. It can be classified into five stages based on GFR.
Top 50 Key Players:
F. Hoffmann-La Roche Ltd
Pfizer Inc
Bayer AG
Novartis AG
Merck & Co Inc
Bristol-Myers Squibb Co
AstraZeneca Plc
Boehringer Ingelheim International GmbH
Regeneron Pharmaceuticals Inc
Hitachi Chemical Co Ltd
OPKO Health Inc
Stada Arzneimittel AG
Boryung Pharmaceutical Co Ltd
Sihuan Pharmaceutical Holdings Group Ltd
Theravance Biopharma Inc
GNI Group Ltd
Unicocell Biomed Co Ltd
Reata Pharmaceuticals Inc
Concert Pharmaceuticals Inc
Ardelyx Inc
DiaMedica Therapeutics Inc
Redx Pharma Plc
Vascular BioSciences
InRegen
Promedior Inc
Wntgen LLC
Allena Pharmaceuticals Inc
Opsidio LLC
OrthoTrophix Inc
Jikei University School of Medicine
Ember Therapeutics Inc (Not Active)
ProKidney LLC
Corvidia Therapeutics Inc
Sentien Biotechnologies Inc
SciGen BioPharma Pvt Ltd
Pharmstandard
AlfaSigma SpA
Liminal BioSciences Inc
Indalo Therapeutics Inc
Dimerix Ltd
Vicore Pharma Holding AB
Osaka University
Resverlogix Corp
Shire Ltd
Angion Biomedica Corp
Cinkate Corp
Renibus Therapeutics Inc
Algernon Pharmaceuticals Inc
Vall d’Hebron Institute of Research.
Algomedix Inc
